Pacing-Induced Heart Failure in the Dog: Evaluation of Peripheral Vascular α-Adrenoceptor Subtypes
- 1 November 1990
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Cardiovascular Pharmacology
- Vol. 16 (5) , 708-718
- https://doi.org/10.1097/00005344-199011000-00004
Abstract
Summary: Postjunctional a-adrenoceptor characteristics were evaluated in canine dorsal pedal arterial and saphenous vein rings studied before and after development of severe pacing-induced heart failure (CHF). Before CHF, all agonists produced concentration-dependent increases in tension of both blood vessels. After development of CHF, the responsiveness and sensitivity of the vessels to the α1-agonists and the mixed agonists were significantly increased as compared with control. The maximum responses to BHT 920 and BHT 933 remained unaltered after CHF, but both vessels showed decreased sensitivity to BHT 920. Before CHF, the rank order of potency with respect to norepinephrine (NE) for the dorsal pedal artery was as follows: NE > epinephrine > methoxamine > BHT 933 > BHT 920, and for the saphenous vein was epinephrine > NE > BHT 933 > methoxamine > BHT 920. At peak CHF, the rank order of potency for the artery was epinephrine > NE> methoxamine > BHT 933 > BHT 920, whereas in the vein BHT 920 was ˜80 times less potent than NE (as compared with being only five times less potent before CHF). Prazosin was a potent, competitive antagonist (pA2 values of 9.2 and 9.0 for the artery and the vein) of methoxamine-induced contractions before development of CHF. Prazosin had a 10-fold lower potency against epinephrine-induced contractions in the dorsal pedal artery, whereas it was not competitive against epinephrine in the saphenous vein. Against the selective α2-aragonists, prazosin either showed no antagonism or was not competitive. After CHF, prazosin was non competitive against all agonists tested. Yohimbine was a potent, competitive antagonist against BHT 920 both before and at CHF. Yohimbine had intermediate antagonism against epinephrine and produced no antagonism of methoxamine-induced contractions. We conclude that increased reactivity and sensitivity of the peripheral vasculature to α1-agonists occurs at CHFKeywords
This publication has 12 references indexed in Scilit:
- Endothelium modulates the effects of α-adrenoceptor agonists in vascular smooth muscleGeneral Pharmacology: The Vascular System, 1988
- α-Adrenergic supersensitivity and decreased number of α-adrenoceptors in heart from acute diabetic ratsCanadian Journal of Physiology and Pharmacology, 1988
- BIPHASIC RELEASE OF ENDOTHELIUM-DERIVED RELAXING FACTOR(S) BY ACETYLCHOLINE FROM PERFUSED CANINE FEMORAL ARTERIES - CHARACTERIZATION OF MUSCARINIC RECEPTORS1987
- The effects on Schild regressions of antagonist removal from the receptor compartment by a saturable processNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1987
- Rapid ventricular pacing in the dog: pathophysiologic studies of heart failure.Circulation, 1986
- Different characteristics of postjunctional alpha-adrenoceptors on arterial and venous smooth muscleNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1984
- α2‐Adrenoceptor agonists potentiate responses mediated by α1‐adrenoceptors in the cat nictitating membraneBritish Journal of Pharmacology, 1984
- The evolution of -adrenergic dysfunction during the induction of canine cobalt cardiomyopathyCardiovascular Research, 1984
- The Renin-Angiotensin-Aldosterone System, Antidiuretic Hormone and Sympathetic Nerve Activity in an Experimental Model of Congestive Heart Failure in the DogClinical Science, 1982
- SOME QUANTITATIVE USES OF DRUG ANTAGONISTSBritish Journal of Pharmacology and Chemotherapy, 1959